Table 3

Multivariate Cox regression analyses of predictors for long-term outcomes

Death (n = 41 873)
Amputation (n = 41 860)
MI (n = 41 860)
Ischaemic stroke (n = 41 873)
HR (95% CI)PHR (95% CI)PHR (95% CI)PHR (95% CI)P
RF 1–31111
RF 42.04 (1.91–2.18)<0.0013.11 (2.76–3.49)<0.0011.32 (1.15–1.51)<0.0011.43 (1.23–1.65)<0.001
RF 52.53 (2.39–2.68)<0.0019.28 (8.47–10.17)<0.0011.29 (1.14–1.47)<0.0011.32 (1.15–1.51)<0.001
RF 63.75 (3.56–3.96)<0.00129.00 (26.67–31.55)<0.0011.29 (1.14–1.46)<0.0011.50 (1.32–1.72)<0.001
Age1.06 (1.06–1.06)<0.0011.00 (1.00–1.00)0.1571.02 (1.02–1.03)<0.0011.03 (1.03–1.04)<0.001
Male1.21 (1.16–1.25)<0.0011.33 (1.27–1.39)<0.0011.27 (1.16–1.40)<0.0011.07 (0.96–1.18)0.226
Hypertension0.83 (0.79–0.86)<0.0010.93 (0.89–0.98)0.0030.91 (0.82–1.00)0.0591.07 (0.96–1.20)0.229
Obesity0.88 (0.81–0.95)0.0020.93 (0.86–1.01)0.1041.03 (0.88–1.21)0.7290.98 (0.81–1.18)0.825
Dyslipidaemia0.74 (0.70–0.77)<0.0010.84 (0.80–0.89)<0.0010.92 (0.83–1.01)0.0910.91 (0.81–1.01)0.083
Smoking1.05 (0.97–1.14)0.2650.835 (0.76–0.92)<0.0010.99 (0.85–1.18)0.9891.07 (0.90–1.28)0.446
Diabetes1.05 (1.00–1.09)0.0331.473 (1.41–1.54)<0.0011.28 (1.17–1.41)<0.0011.30 (1.17–1.44)<0.001
CAD1.24 (1.19–1.30)<0.0011.00 (0.95–1.05)0.9762.02 (1.84–2.22)<0.0010.97 (0.86–1.09)0.554
CHF1.62 (1.54–1.70)<0.0011.10 (1.03–1.17)0.0031.64 (1.44–1.85)<0.0011.27 (1.09–1.49)0.002
CKD1.47 (1.41–1.53)<0.0011.12 (1.07–1.18)<0.0011.30 (1.17–1.44)<0.0011.05 (0.93–1.18)0.439
Malignancies2.16 (1.96–2.38)<0.0010.91 (0.78–1.05)0.2031.14 (0.82–1.58)0.4280.97 (0.65–1.44)0.874
Harrell's Ca0.780.850.680.64
Death (n = 41 873)
Amputation (n = 41 860)
MI (n = 41 860)
Ischaemic stroke (n = 41 873)
HR (95% CI)PHR (95% CI)PHR (95% CI)PHR (95% CI)P
RF 1–31111
RF 42.04 (1.91–2.18)<0.0013.11 (2.76–3.49)<0.0011.32 (1.15–1.51)<0.0011.43 (1.23–1.65)<0.001
RF 52.53 (2.39–2.68)<0.0019.28 (8.47–10.17)<0.0011.29 (1.14–1.47)<0.0011.32 (1.15–1.51)<0.001
RF 63.75 (3.56–3.96)<0.00129.00 (26.67–31.55)<0.0011.29 (1.14–1.46)<0.0011.50 (1.32–1.72)<0.001
Age1.06 (1.06–1.06)<0.0011.00 (1.00–1.00)0.1571.02 (1.02–1.03)<0.0011.03 (1.03–1.04)<0.001
Male1.21 (1.16–1.25)<0.0011.33 (1.27–1.39)<0.0011.27 (1.16–1.40)<0.0011.07 (0.96–1.18)0.226
Hypertension0.83 (0.79–0.86)<0.0010.93 (0.89–0.98)0.0030.91 (0.82–1.00)0.0591.07 (0.96–1.20)0.229
Obesity0.88 (0.81–0.95)0.0020.93 (0.86–1.01)0.1041.03 (0.88–1.21)0.7290.98 (0.81–1.18)0.825
Dyslipidaemia0.74 (0.70–0.77)<0.0010.84 (0.80–0.89)<0.0010.92 (0.83–1.01)0.0910.91 (0.81–1.01)0.083
Smoking1.05 (0.97–1.14)0.2650.835 (0.76–0.92)<0.0010.99 (0.85–1.18)0.9891.07 (0.90–1.28)0.446
Diabetes1.05 (1.00–1.09)0.0331.473 (1.41–1.54)<0.0011.28 (1.17–1.41)<0.0011.30 (1.17–1.44)<0.001
CAD1.24 (1.19–1.30)<0.0011.00 (0.95–1.05)0.9762.02 (1.84–2.22)<0.0010.97 (0.86–1.09)0.554
CHF1.62 (1.54–1.70)<0.0011.10 (1.03–1.17)0.0031.64 (1.44–1.85)<0.0011.27 (1.09–1.49)0.002
CKD1.47 (1.41–1.53)<0.0011.12 (1.07–1.18)<0.0011.30 (1.17–1.44)<0.0011.05 (0.93–1.18)0.439
Malignancies2.16 (1.96–2.38)<0.0010.91 (0.78–1.05)0.2031.14 (0.82–1.58)0.4280.97 (0.65–1.44)0.874
Harrell's Ca0.780.850.680.64

CAD, coronary artery disease; CHF, chronic heart failure, CKD, chronic kidney disease; CI, confidence interval; HR, hazard ratio; MI, myocardial infarction; RF, Rutherford category.

Comorbidities were defined on the basis of given ICD-10 codes, and are presented in detail in Supplementary material online, Table S1.

Significant P-values were presented in bold.

aA value for Harrell's C = 0.5 suggests no discrimination; 0.7 ≤ C < 0.8 is considered acceptable discrimination; 0.8 ≤ C < 0.9 is considered as excellent discrimination; C ≥ 0.9 is considered as outstanding discrimination.

Table 3

Multivariate Cox regression analyses of predictors for long-term outcomes

Death (n = 41 873)
Amputation (n = 41 860)
MI (n = 41 860)
Ischaemic stroke (n = 41 873)
HR (95% CI)PHR (95% CI)PHR (95% CI)PHR (95% CI)P
RF 1–31111
RF 42.04 (1.91–2.18)<0.0013.11 (2.76–3.49)<0.0011.32 (1.15–1.51)<0.0011.43 (1.23–1.65)<0.001
RF 52.53 (2.39–2.68)<0.0019.28 (8.47–10.17)<0.0011.29 (1.14–1.47)<0.0011.32 (1.15–1.51)<0.001
RF 63.75 (3.56–3.96)<0.00129.00 (26.67–31.55)<0.0011.29 (1.14–1.46)<0.0011.50 (1.32–1.72)<0.001
Age1.06 (1.06–1.06)<0.0011.00 (1.00–1.00)0.1571.02 (1.02–1.03)<0.0011.03 (1.03–1.04)<0.001
Male1.21 (1.16–1.25)<0.0011.33 (1.27–1.39)<0.0011.27 (1.16–1.40)<0.0011.07 (0.96–1.18)0.226
Hypertension0.83 (0.79–0.86)<0.0010.93 (0.89–0.98)0.0030.91 (0.82–1.00)0.0591.07 (0.96–1.20)0.229
Obesity0.88 (0.81–0.95)0.0020.93 (0.86–1.01)0.1041.03 (0.88–1.21)0.7290.98 (0.81–1.18)0.825
Dyslipidaemia0.74 (0.70–0.77)<0.0010.84 (0.80–0.89)<0.0010.92 (0.83–1.01)0.0910.91 (0.81–1.01)0.083
Smoking1.05 (0.97–1.14)0.2650.835 (0.76–0.92)<0.0010.99 (0.85–1.18)0.9891.07 (0.90–1.28)0.446
Diabetes1.05 (1.00–1.09)0.0331.473 (1.41–1.54)<0.0011.28 (1.17–1.41)<0.0011.30 (1.17–1.44)<0.001
CAD1.24 (1.19–1.30)<0.0011.00 (0.95–1.05)0.9762.02 (1.84–2.22)<0.0010.97 (0.86–1.09)0.554
CHF1.62 (1.54–1.70)<0.0011.10 (1.03–1.17)0.0031.64 (1.44–1.85)<0.0011.27 (1.09–1.49)0.002
CKD1.47 (1.41–1.53)<0.0011.12 (1.07–1.18)<0.0011.30 (1.17–1.44)<0.0011.05 (0.93–1.18)0.439
Malignancies2.16 (1.96–2.38)<0.0010.91 (0.78–1.05)0.2031.14 (0.82–1.58)0.4280.97 (0.65–1.44)0.874
Harrell's Ca0.780.850.680.64
Death (n = 41 873)
Amputation (n = 41 860)
MI (n = 41 860)
Ischaemic stroke (n = 41 873)
HR (95% CI)PHR (95% CI)PHR (95% CI)PHR (95% CI)P
RF 1–31111
RF 42.04 (1.91–2.18)<0.0013.11 (2.76–3.49)<0.0011.32 (1.15–1.51)<0.0011.43 (1.23–1.65)<0.001
RF 52.53 (2.39–2.68)<0.0019.28 (8.47–10.17)<0.0011.29 (1.14–1.47)<0.0011.32 (1.15–1.51)<0.001
RF 63.75 (3.56–3.96)<0.00129.00 (26.67–31.55)<0.0011.29 (1.14–1.46)<0.0011.50 (1.32–1.72)<0.001
Age1.06 (1.06–1.06)<0.0011.00 (1.00–1.00)0.1571.02 (1.02–1.03)<0.0011.03 (1.03–1.04)<0.001
Male1.21 (1.16–1.25)<0.0011.33 (1.27–1.39)<0.0011.27 (1.16–1.40)<0.0011.07 (0.96–1.18)0.226
Hypertension0.83 (0.79–0.86)<0.0010.93 (0.89–0.98)0.0030.91 (0.82–1.00)0.0591.07 (0.96–1.20)0.229
Obesity0.88 (0.81–0.95)0.0020.93 (0.86–1.01)0.1041.03 (0.88–1.21)0.7290.98 (0.81–1.18)0.825
Dyslipidaemia0.74 (0.70–0.77)<0.0010.84 (0.80–0.89)<0.0010.92 (0.83–1.01)0.0910.91 (0.81–1.01)0.083
Smoking1.05 (0.97–1.14)0.2650.835 (0.76–0.92)<0.0010.99 (0.85–1.18)0.9891.07 (0.90–1.28)0.446
Diabetes1.05 (1.00–1.09)0.0331.473 (1.41–1.54)<0.0011.28 (1.17–1.41)<0.0011.30 (1.17–1.44)<0.001
CAD1.24 (1.19–1.30)<0.0011.00 (0.95–1.05)0.9762.02 (1.84–2.22)<0.0010.97 (0.86–1.09)0.554
CHF1.62 (1.54–1.70)<0.0011.10 (1.03–1.17)0.0031.64 (1.44–1.85)<0.0011.27 (1.09–1.49)0.002
CKD1.47 (1.41–1.53)<0.0011.12 (1.07–1.18)<0.0011.30 (1.17–1.44)<0.0011.05 (0.93–1.18)0.439
Malignancies2.16 (1.96–2.38)<0.0010.91 (0.78–1.05)0.2031.14 (0.82–1.58)0.4280.97 (0.65–1.44)0.874
Harrell's Ca0.780.850.680.64

CAD, coronary artery disease; CHF, chronic heart failure, CKD, chronic kidney disease; CI, confidence interval; HR, hazard ratio; MI, myocardial infarction; RF, Rutherford category.

Comorbidities were defined on the basis of given ICD-10 codes, and are presented in detail in Supplementary material online, Table S1.

Significant P-values were presented in bold.

aA value for Harrell's C = 0.5 suggests no discrimination; 0.7 ≤ C < 0.8 is considered acceptable discrimination; 0.8 ≤ C < 0.9 is considered as excellent discrimination; C ≥ 0.9 is considered as outstanding discrimination.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close